Leading the way
Leading the way
committed to excellence
committed
to excellence
About Us
Discover eXinvest
eXinvest is an acronym of “extreme investments & holding company”, and it embodies all the business selection, know-how and connections of its shareholders.
496
Suppliers worldwide
892
Analysed supply proposals 2023/2024
216
Affiliated pharmaceutical brokers
2
Open projects in clinics and hospitals
14
Open annual project - Pharmaceutical contracts
1
Open project in Mobile clinics - Emergency facilities
> 50M USD
More than USD 50 million order backlog between Liechtenstein and Dubai
Latest
-
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position
-
22. October 2025eXinvest of Emirates Named Exclusive UAE and GCC Distributor for Helan, Bringing Premium Kids’ Cosmetics to the Arabian Peninsula
-
22. October 2025eXinvest of Emirates Launches Controcyst in UAE and GCC, Seeking Exclusive Distribution Partners for Innovative Pelvic Pain Solution
-
21. October 2025eXinvest of Emirates Appointed Exclusive UAE Distributor for ViPlus, Expanding Premium Dairy into the GCC Market
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position
-
22. October 2025eXinvest of Emirates Named Exclusive UAE and GCC Distributor for Helan, Bringing Premium Kids’ Cosmetics to the Arabian Peninsula
-
22. October 2025eXinvest of Emirates Launches Controcyst in UAE and GCC, Seeking Exclusive Distribution Partners for Innovative Pelvic Pain Solution
-
21. October 2025eXinvest of Emirates Appointed Exclusive UAE Distributor for ViPlus, Expanding Premium Dairy into the GCC Market